Inflammatory aneurysm of the abdominal aorta in a patient treated with ropinirole.
Parissis
Dimitrios
D
Papachristodoulou
Athanasia
A
Dimitriadis
Athanasios
A
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D017544:Aortic Aneurysm, Abdominal / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007249:Inflammation / Q000139:chemically induced / Q000473:pathology; D008297:Male; D011859:Radiography; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology*; D014657:Vasculitis / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology*
D000978:Antiparkinson Agents; D007211:Indoles; C046649:ropinirole
Lancet. 2006 Jan 21;367(9506):241-51
16427494
Best Pract Res Clin Rheumatol. 2009 Jun;23(3):339-53
19508942
Mol Pharmacol. 2009 Oct;76(4):710-22
19570945
J Mol Med (Berl). 2007 Oct;85(10):1077-88
17522832
Mov Disord. 2004 Jun;19(6):699-704
15197712
J Neural Transm (Vienna). 2009 Feb;116(2):179-91
19142570
Eur J Intern Med. 2005 Apr;16(2):129-131
15833682
Clin Neuropharmacol. 2003 May-Jun;26(3):109-11
12782910
Mov Disord. 2009 Jan 15;24(1):129-33
19170199